{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:25:36Z","timestamp":1789979136727,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","aggjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Gerontology and Geriatrics"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.archger.2016.04.008","type":"journal-article","created":{"date-parts":[[2016,4,13]],"date-time":"2016-04-13T19:45:01Z","timestamp":1460576701000},"page":"248-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The role of comprehensive geriatric assessment and functional status in evaluating the patterns of antithrombotic use among older people with atrial fibrillation"],"prefix":"10.1016","volume":"65","author":[{"given":"A.","family":"Mazzone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lucenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bellelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Annoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.archger.2016.04.008_bib0005","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1253\/circj.CJ-14-0344","article-title":"Fushimi AFRI. Inappropriate use of oral anticoagulants for patients with atrial fibrillation","volume":"78","author":"Akao","year":"2014","journal-title":"Circulation Journal"},{"key":"10.1016\/j.archger.2016.04.008_bib0010","series-title":"Diagnostic and statistical manual of mental disorders: DSM-IV-TR","author":"American Psychiatric A","year":"2000"},{"key":"10.1016\/j.archger.2016.04.008_bib0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jgs.13200","article-title":"Underuse of oral anticoagulation for individuals with atrial fibrillation in a nursing home setting in France: comparisons of resident characteristics and physician attitude","volume":"63","author":"Bahri","year":"2015","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.archger.2016.04.008_bib0020","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1160\/TH11-11-0784","article-title":"Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a \u2018real world\u2019 atrial fibrillation population: a modelling analysis based on a nationwide cohort study","volume":"107","author":"Banerjee","year":"2012","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.archger.2016.04.008_bib0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archinte.162.1.107","article-title":"Anticoagulation treatment in disabled patients","volume":"162","author":"Bellelli","year":"2002","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.archger.2016.04.008_bib0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archinte.160.1.41","article-title":"Why do patients with atrial fibrillation not receive warfarin?","volume":"160","author":"Bungard","year":"2000","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.archger.2016.04.008_bib0035","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","volume":"33","author":"Camm","year":"2012","journal-title":"European Heart Journal"},{"key":"10.1016\/j.archger.2016.04.008_bib0040","doi-asserted-by":"crossref","first-page":"302","DOI":"10.18553\/jmcp.2013.19.4.302","article-title":"The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective","volume":"19","author":"Casciano","year":"2013","journal-title":"Journal of Managed Care Pharmacy"},{"key":"10.1016\/j.archger.2016.04.008_bib0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"Journal of Chronic Diseases"},{"key":"10.1016\/j.archger.2016.04.008_bib0050","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2165\/11537900-000000000-00000","article-title":"Could geriatric characteristics explain the under-prescription of anticoagulation therapy for older patients admitted with atrial fibrillation? A retrospective observational study","volume":"27","author":"De Breucker","year":"2010","journal-title":"Drugs and Aging"},{"key":"10.1016\/j.archger.2016.04.008_bib0055","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/j.ijcard.2012.07.019","article-title":"Investigators A-A. Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATA AF study","volume":"167","author":"Di Pasquale","year":"2013","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.archger.2016.04.008_bib0060","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1472-8206.2008.00629.x","article-title":"Which parameters differ in very old patients with chronic atrial fibrillation treated by anticoagulant or aspirin? Antithrombotic treatment of atrial fibrillation in the elderly","volume":"22","author":"Doucet","year":"2008","journal-title":"Fundamental and Clinical Pharmacology"},{"key":"10.1016\/j.archger.2016.04.008_bib0065","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1532-5415.2011.03508.x","article-title":"Atrial fibrillation and risk of dementia: a prospective cohort study","volume":"59","author":"Dublin","year":"2011","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.archger.2016.04.008_bib0070","first-page":"1012","article-title":"Investigators A. Non-valvular atrial fibrillation in the elderly; preliminary results from the National AFTER (Atrial Fibrillation in Turkey: Epidemiologic Registry) Study","volume":"17","author":"Ertas","year":"2013","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1016\/j.archger.2016.04.008_bib0075","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jacc.2007.09.065","article-title":"Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation","volume":"51","author":"Fang","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.archger.2016.04.008_bib0080","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.archger.2016.04.008_bib0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/joim.12114","article-title":"Atrial fibrillation prevalence revisited","volume":"274","author":"Friberg","year":"2013","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.archger.2016.04.008_bib0090","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.111.055079","article-title":"Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study","volume":"125","author":"Friberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.archger.2016.04.008_bib0095","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/CIRCULATIONAHA.112.135681","article-title":"Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation","volume":"126","author":"Gallego","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.archger.2016.04.008_bib0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.acvd.2014.01.001","article-title":"Realise AFi Use of antithrombotics in atrial fibrillation in Africa, Europe, Asia and South America: insights from the International RealiseAF Survey","volume":"107","author":"Gamra","year":"2014","journal-title":"Archives of Cardiovascular Diseases"},{"key":"10.1016\/j.archger.2016.04.008_bib0105","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.archger.2016.04.008_bib0110","doi-asserted-by":"crossref","first-page":"e71264","DOI":"10.1371\/journal.pone.0071264","article-title":"Quality of life, activity impairment, and healthcare resource utilization associated with atrial fibrillation in the US National Health and Wellness Survey","volume":"8","author":"Goren","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.archger.2016.04.008_bib0115","series-title":"Regression modeling strategies with applications to linear models, logistic regression, and survival analysis","author":"Harrell","year":"2001"},{"key":"10.1016\/j.archger.2016.04.008_bib0120","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.archger.2016.04.008_bib0125","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"Stroke prevention in atrial fibrillation study. Final results","volume":"84","author":"Investigators SPiAF","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.archger.2016.04.008_bib0130","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"Members AATF: 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.archger.2016.04.008_bib0135","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s12603-009-0214-7","article-title":"Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status","volume":"13","author":"Kaiser","year":"2009","journal-title":"Journal of Nutrition, Health and Aging"},{"key":"10.1016\/j.archger.2016.04.008_bib0140","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","article-title":"Studies of illness in the aged. The Index of Adl: a standardized measure of biological and psychosocial function","volume":"185","author":"Katz","year":"1963","journal-title":"JAMA"},{"key":"10.1016\/j.archger.2016.04.008_bib0145","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2013.12.022","article-title":"\u2018Real-world\u2019 antithrombotic treatment in atrial fibrillation: the EORP-AF pilot survey","volume":"127","author":"Lip","year":"2014","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.archger.2016.04.008_bib0150","first-page":"1091","article-title":"Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?","volume":"9","author":"Maes","year":"2014","journal-title":"Clinical Interventions in Aging"},{"key":"10.1016\/j.archger.2016.04.008_bib0155","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Midland Research Practices N Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.archger.2016.04.008_bib0160","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ejim.2010.07.014","article-title":"Investigators R. Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards","volume":"21","author":"Marcucci","year":"2010","journal-title":"European Journal of Internal Medicine"},{"key":"10.1016\/j.archger.2016.04.008_bib0165","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","article-title":"Underuse of oral anticoagulants in atrial fibrillation: a systematic review","volume":"123","author":"Ogilvie","year":"2010","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.archger.2016.04.008_bib0170","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/gerona\/glr233","article-title":"Polypharmacy in nursing home in Europe: results from the SHELTER study","volume":"67","author":"Onder","year":"2012","journal-title":"The Journals of Gerontology Series A: Biological Sciences and Medical Sciences"},{"key":"10.1016\/j.archger.2016.04.008_bib0175","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ageing\/afn293","article-title":"The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation","volume":"38","author":"Perera","year":"2009","journal-title":"Age and Ageing"},{"key":"10.1016\/j.archger.2016.04.008_bib0180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.archger.2016.04.008_bib0185","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s40266-013-0127-3","article-title":"Use of vitamin K antagonist therapy in geriatrics: a French national survey from the French Society of Geriatrics and Gerontology (SFGG)","volume":"30","author":"Plichart","year":"2013","journal-title":"Drugs and Aging"},{"key":"10.1016\/j.archger.2016.04.008_bib0190","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/ageing\/afr097","article-title":"Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review","volume":"40","author":"Pugh","year":"2011","journal-title":"Age and Ageing"},{"key":"10.1016\/j.archger.2016.04.008_bib0195","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/gerona\/60.9.1180","article-title":"Relationship between functional loss before hospital admission and mortality in elderly persons with medical illness","volume":"60","author":"Rozzini","year":"2005","journal-title":"The Journals of Gerontology Series A: Biological Sciences and Medical Sciences"},{"key":"10.1016\/j.archger.2016.04.008_bib0200","first-page":"81","article-title":"Multidimensional assessment of elderly patients","volume":"36","author":"Rubenstein","year":"1991","journal-title":"Advances in Internal Medicine"},{"key":"10.1016\/j.archger.2016.04.008_bib0205","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1111\/j.1532-5415.1991.tb05927.x","article-title":"Impacts of geriatric evaluation and management programs on defined outcomes: overview of the evidence","volume":"39","author":"Rubenstein","year":"1991","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.archger.2016.04.008_bib0210","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1111\/jgs.12582","article-title":"Are geriatric syndromes associated with reluctance to initiate oral anticoagulation therapy in elderly adults with nonvalvular atrial fibrillation?","volume":"61","author":"Sanchez-Barba","year":"2013","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.archger.2016.04.008_bib0215","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/heartjnl-2012-302843","article-title":"Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000\u20132009","volume":"99","author":"Scowcroft","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.archger.2016.04.008_bib0220","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","article-title":"The net clinical benefit of warfarin anticoagulation in atrial fibrillation","volume":"151","author":"Singer","year":"2009","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.archger.2016.04.008_bib0225","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/europace\/eun054","article-title":"Mortality in patients with atrial fibrillation: improving or not?","volume":"10","author":"Taggar","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.archger.2016.04.008_bib0230","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40256-013-0040-5","article-title":"Factors associated with undertreatment of atrial fibrillation in geriatric outpatients with Alzheimer disease","volume":"13","author":"Tavassoli","year":"2013","journal-title":"American Journal of Cardiovascular Drugs"},{"key":"10.1016\/j.archger.2016.04.008_bib0235","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/11319540-000000000-00000","article-title":"Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study","volume":"27","author":"Tulner","year":"2010","journal-title":"Drugs and Aging"},{"key":"10.1016\/j.archger.2016.04.008_bib0240","first-page":"330","article-title":"Consensus statement on dementia of Alzheimer type in the severe stage","volume":"9","author":"Vellas","year":"2005","journal-title":"Journal of Nutrition, Health and Aging"},{"key":"10.1016\/j.archger.2016.04.008_bib0245","series-title":"Regression methods in biostatistics","author":"Vittinghoff","year":"2012"},{"key":"10.1016\/j.archger.2016.04.008_bib0250","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.10.006","article-title":"Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry","volume":"23","author":"Wang","year":"2014","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1016\/j.archger.2016.04.008_bib0255","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/europace\/eus333","article-title":"Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients","volume":"15","author":"Wilke","year":"2013","journal-title":"Europace"}],"container-title":["Archives of Gerontology and Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167494316300723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167494316300723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T11:21:43Z","timestamp":1536837703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167494316300723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":51,"alternative-id":["S0167494316300723"],"URL":"https:\/\/doi.org\/10.1016\/j.archger.2016.04.008","relation":{},"ISSN":["0167-4943"],"issn-type":[{"value":"0167-4943","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of comprehensive geriatric assessment and functional status in evaluating the patterns of antithrombotic use among older people with atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Archives of Gerontology and Geriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.archger.2016.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}